首页> 外文OA文献 >Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket
【2h】

Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket

机译:核糖体肽基转移酶中心的单个23S rRNA突变通过扰动药物结合袋而赋予耻垢分枝杆菌对缬氨菌素和其他抗生素的抗性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tiamulin and valnemulin target the peptidyl transferase centre (PTC) on the bacterial ribosome. They are used in veterinary medicine to treat infections caused by a variety of bacterial pathogens, including the intestinal spirochetes Brachyspira spp. Mutations in ribosomal protein L3 and 23S rRNA have previously been associated with tiamulin resistance in Brachyspira spp. isolates, but as multiple mutations were isolated together, the roles of the individual mutations are unclear. In this work, individual 23S rRNA mutations associated with pleuromutilin resistance at positions 2055, 2447, 2504 and 2572 (Escherichia coli numbering) are introduced into a Mycobacterium smegmatis strain with a single rRNA operon. The single mutations each confer a significant and similar degree of valnemulin resistance and those at 2447 and 2504 also confer cross-resistance to other antibiotics that bind to the PTC in M. smegmatis. Antibiotic footprinting experiments on mutant ribosomes show that the introduced mutations cause structural perturbations at the PTC and reduced binding of pleuromutilin antibiotics. This work underscores the fact that mutations at nucleotides distant from the pleuromutilin binding site can confer the same level of valnemulin resistance as those at nucleotides abutting the bound drug, and suggests that the former function indirectly by altering local structure and flexibility at the drug binding pocket.
机译:Tiamulin和Valnemulin靶向细菌核糖体上的肽基转移酶中心(PTC)。它们用于兽医,以治疗由多种细菌性病原体引起的感染,包括肠道螺旋体Brachyspira spp。核糖体蛋白L3和23S rRNA的突变以前曾与短螺旋体属中的头孢菌素耐药有关。分离,但由于多个突变被一起分离,单个突变的作用尚不清楚。在这项工作中,将与在2055、2447、2504和2572位(对大肠杆菌编号)的截短侧耳素抗性相关的单个23S rRNA突变引入具有单个rRNA操纵子的耻垢分枝杆菌菌株。单个突变均赋予了显着和相似程度的缬氨莫林耐药性,而在2447和2504处的突变也赋予了与耻垢分枝杆菌中与PTC结合的其他抗生素的交叉耐药性。在突变核糖体上进行的抗生素足迹实验表明,引入的突变在PTC处引起结构扰动,并降低了截短侧耳素抗生素的结合。这项工作强调了这样一个事实,即远离截短侧耳素结合位点的核苷酸处的突变可赋予与邻接药物的核苷酸相同水平的缬氨莫林耐药性,并表明前者通过改变药物结合口袋的局部结构和柔性而间接起作用。 。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号